MX2025003151A - Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigida - Google Patents
Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigidaInfo
- Publication number
- MX2025003151A MX2025003151A MX2025003151A MX2025003151A MX2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- amino acid
- minigastrin
- imaging
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22196630 | 2022-09-20 | ||
| PCT/EP2023/063469 WO2024061483A1 (en) | 2022-09-20 | 2023-05-19 | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2025003151A true MX2025003151A (es) | 2025-04-02 |
Family
ID=83994946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2025003151A MX2025003151A (es) | 2022-09-20 | 2025-03-18 | Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigida |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP4590347A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025532619A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250073200A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119907695A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023345654A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3264385A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL319379A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025003151A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024061483A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12642876B1 (en) | 2025-10-30 | 2026-06-02 | Perspective Therapeutics, Inc. | Cholecystokinin-2 receptor targeted compounds and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3412303A1 (en) * | 2017-06-08 | 2018-12-12 | Medizinische Universität Innsbruck | Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy |
| KR20240027896A (ko) * | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| EP4023250A1 (en) * | 2021-01-04 | 2022-07-06 | Technische Universität München | Dual mode radiotracer and -therapeutics |
-
2023
- 2023-05-19 CA CA3264385A patent/CA3264385A1/en active Pending
- 2023-05-19 IL IL319379A patent/IL319379A/en unknown
- 2023-05-19 EP EP23727562.3A patent/EP4590347A1/en active Pending
- 2023-05-19 WO PCT/EP2023/063469 patent/WO2024061483A1/en not_active Ceased
- 2023-05-19 JP JP2025515980A patent/JP2025532619A/ja active Pending
- 2023-05-19 AU AU2023345654A patent/AU2023345654A1/en active Pending
- 2023-05-19 KR KR1020257012384A patent/KR20250073200A/ko active Pending
- 2023-05-19 EP EP25193071.5A patent/EP4631959A3/en active Pending
- 2023-05-19 CN CN202380067423.2A patent/CN119907695A/zh active Pending
-
2025
- 2025-03-18 MX MX2025003151A patent/MX2025003151A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20250073200A (ko) | 2025-05-27 |
| CA3264385A1 (en) | 2024-03-28 |
| CN119907695A (zh) | 2025-04-29 |
| JP2025532619A (ja) | 2025-10-01 |
| AU2023345654A1 (en) | 2025-02-27 |
| WO2024061483A1 (en) | 2024-03-28 |
| EP4590347A1 (en) | 2025-07-30 |
| IL319379A (en) | 2025-05-01 |
| EP4631959A3 (en) | 2025-12-17 |
| EP4631959A2 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2437983A1 (en) | Transporters comprising spaced arginine moieties | |
| Lejczak et al. | Antibacterial activity of phosphono dipeptides related to alafosfalin | |
| DK2496596T3 (en) | THERAPEUTIC PEPTIDES | |
| JP2016527186A5 (cg-RX-API-DMAC7.html) | ||
| WO2004016274B1 (en) | Novel peptide-conjugated oligomeric compounds | |
| RU2015148032A (ru) | Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками | |
| DE69417049D1 (de) | Hydroxamsäurederivate als inhibitoren von cylokine produktion | |
| MX2022002696A (es) | Composiciones de peptoides antivirales. | |
| HRP950276A2 (en) | New amino acid derivatives, process for their preparation and pharmaceutical compounds (ii) containing such compounds | |
| AU2009292741B8 (en) | Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof | |
| RU2015100521A (ru) | Новые циклические депсипептидные производные и средства для борьбы с вредными организмами, включающие такие производные | |
| HK1216029A1 (zh) | β-发夹肽模拟物 | |
| JPWO2022191283A5 (cg-RX-API-DMAC7.html) | ||
| WO2020167831A1 (en) | Method of preparing a don prodrug from l-glutamic acid | |
| EA014959B3 (ru) | Ингибиторы глицинового переносчика-1 | |
| EP2421893A2 (en) | Short-chain peptides as parathyroid hormone (pth) receptor agonist | |
| US6753431B2 (en) | Production of mixed acid anhydride and amide compound | |
| AU2013277637B2 (en) | Synthesis of beta-turn peptidomimetic cyclic compounds | |
| DE602004029497D1 (de) | Neue proteasommodulatoren | |
| EA200400603A1 (ru) | Новые пептиды - аналоги гормона высвобождения гормона роста человека | |
| US20220185841A1 (en) | Method for producing peptide compound, reagent for forming protective group, and hydrazine derivative | |
| DK1144421T3 (da) | Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser | |
| CA3228897A1 (en) | Polypeptide drug conjugate having novel structure and application thereof | |
| PL441789A1 (pl) | Lipooligomoczniki, kompozycja farmaceutyczna, oraz lipooligomoczniki do zastosowania jako lek | |
| Rodrigues et al. | Synthesis and conformational investigation of tetrapeptide analogues of the fragment B23-B26 of insulin |